Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies

被引：4
作者：
Di Minno, Matteo Nicola Dario [1 ]
Minno, Alessandro Di [2 ]
Calcaterra, Ilenia [3 ]
Cimino, Ernesto [3 ]
Dell'Aquila, Francesco [3 ]
Franchini, Massimo [4 ]
机构：
[1] Univ Naples Federico II, Dept Translat Med Sci, Via S Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Farm, Naples, Italy
[3] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[4] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2022年 / 48卷 / 02期
关键词：
D O I：
10.1055/s-0041-1740148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 8 条
  • [1] Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A
    Chowdary, Pratima
    Mullins, Eric S.
    Konkle, Barbara A.
    McGuinn, Catherine
    Park, Young Shil
    Stasyshyn, Oleksandra
    Zulfikar, Bulent
    Engl, Werner
    Tangada, Srilatha
    [J]. HAEMOPHILIA, 2020, 26 (04) : E168 - E178
  • [2] Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies
    Di Minno, Matteo Nicola Dario
    Di Minno, Alessandro
    Calcaterra, Ilenia
    Cimino, Ernesto
    Dell'Aquila, Francesco
    Franchini, Massimo
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (01) : 32 - 42
  • [3] Long-term safety and efficacy of N8-GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
    Giangrande, Paul
    Abdul Karim, Faraizah
    Nemes, Laszlo
    You, Chur Woo
    Landorph, Andrea
    Geybels, Milan S.
    Curry, Nicola
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 : 5 - 14
  • [4] Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies"
    Horneff, Regina
    Bystricka, Linda
    Santagostino, Elena
    Lethagen, Stefan
    Casiano, Sandra
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (02) : 251 - 252
  • [5] Outcome measures in Haemophilia: Beyond ABR (Annualized Bleeding Rate)
    Manco-Johnson, Marilyn J.
    Warren, Beth Boulden
    Buckner, Tyler W.
    Funk, Sharon M.
    Wang, Michael
    [J]. HAEMOPHILIA, 2021, 27 : 87 - 95
  • [6] Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A
    Mannucci, Pier Mannuccio
    Cortesi, Paolo Angelo
    Di Minno, Matteo Nicola Dario
    Sano, Mario
    Mantovani, Lorenzo Giovanni
    Di Minno, Giovanni
    [J]. HAEMOPHILIA, 2021, 27 (04) : E422 - E433
  • [7] Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study
    Nolan, Beatrice
    Mahlangu, Johnny
    Pabinger, Ingrid
    Young, Guy
    Konkle, Barbara A.
    Barnes, Chris
    Nogami, Keiji
    Santagostino, Elena
    Pasi, K. John
    Khoo, Liane
    Winding, Bent
    Yuan, Huixing
    Fruebis, Joachim
    Rudin, Dan
    Oldenburg, Johannes
    [J]. HAEMOPHILIA, 2020, 26 (03) : 494 - 502
  • [8] Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
    Reding, Mark T.
    Pabinger, Ingrid
    Holme, Pal Andre
    Poulsen, Lone
    Negrier, Claude
    Chalasani, Pavani
    Enriquez, Monika Maas
    Wang, Maria
    Meijer, Karina
    Mancuso, Maria Elisa
    Lalezari, Shadan
    [J]. HAEMOPHILIA, 2021, 27 (03) : E347 - E356
1